litlas
Log inCreate account

Gerd Ritter

Active 1989–2021

96
Papers
17,990
Citations
78
h-index
91
i10-index

Citations

Citations per year for Gerd Ritter1990: 1 citations1991: 7 citations1992: 6 citations1993: 11 citations1994: 16 citations1995: 15 citations1996: 17 citations1997: 20 citations1998: 27 citations1999: 37 citations2000: 53 citations2001: 84 citations2002: 99 citations2003: 125 citations2004: 165 citations2005: 178 citations2006: 187 citations2007: 202 citations2008: 221 citations2009: 216 citations2010: 216 citations2011: 218 citations2012: 245 citations2013: 210 citations2014: 193 citations2015: 244 citations2016: 188 citations2017: 186 citations2018: 191 citations2019: 513 citations2020: 493 citations2021: 444 citations2022: 334 citations2023: 220 citations2024: 263 citations2025: 122 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,217 citing papers, 32.9% of this breakdownChina: 589 citing papers, 8.7% of this breakdownGermany: 398 citing papers, 5.9% of this breakdownUnited Kingdom: 372 citing papers, 5.5% of this breakdownAustralia: 280 citing papers, 4.1% of this breakdownJapan: 262 citing papers, 3.9% of this breakdownFrance: 249 citing papers, 3.7% of this breakdownItaly: 234 citing papers, 3.5% of this breakdownCanada: 214 citing papers, 3.2% of this breakdownNetherlands: 203 citing papers, 3% of this breakdownSwitzerland: 193 citing papers, 2.9% of this breakdownBelgium: 119 citing papers, 1.8% of this breakdown
0%32.9%Other 20.9%

Institutions

Fields

  • Medicine40.7%
  • Immunology and Microbiology34.9%
  • Biochemistry, Genetics and Molecular Biology18.1%
  • Materials Science1.4%
  • Computer Science1.3%
  • Engineering1%
  • Other2.6%

Topics

  • Immunotherapy and Immune Responses13.1%
  • Cancer Immunotherapy and Biomarkers8.8%
  • Immune Cell Function and Interaction7.8%
  • CAR-T cell therapy research5.2%
  • T-cell and B-cell Immunology4.5%
  • Monoclonal and Polyclonal Antibodies Research3.2%
  • Other57.4%

Coauthors

All papers

Open in search
  1. Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 + /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

    Authors: Eiichi Sato, Sara H. Olson, Jiyoung Ahn, Brian N. Bundy, Hiroyoshi Nishikawa, Feng Qian, Achim A. Jungbluth, Denise Frosina, Sacha Gnjatic, Christine B. Ambrosone, James L. Kepner, Tosin Odunsi, Gerd Ritter, Shashikant Lele, Yao‐Tseng Chen, Haruo Ohtani, Lloyd J. Old, Kunle Odunsi - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 2,389

  2. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

    Authors: Andrew M. Scott, G. Wiseman, Sydney Welt, Alex A. Adjei, Fook-Thean Lee, Wendie Hopkins, C R Divgi, Lorelei H Hanson, Paul Mitchell, Denise N. Gansen, Steven M. Larson, James N. Ingle, Eric W. Hoffman, P. Tanswell, Gerd Ritter, Leonard Cohen, Peter Bette, Lisa Arvay, A. Amelsberg, Dan Vlock, Wolfgang J. Rettig, Lloyd J. Old - 2003 cited by 442

  3. Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity

    Authors: Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Markus Maeurer, Erika Ritter, Takamasa Tsuji, Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Elke Jäger - Clinical Cancer Research 2012 cited by 99

  4. NY‐ESO‐1: Review of an Immunogenic Tumor Antigen

    Authors: Sacha Gnjatic, Hiroyoshi Nishikawa, Achim A. Jungbluth, Ali O. Güre, Gerd Ritter, Elke Jäger, Alexander Knuth, Yao‐Tseng Chen, Lloyd J. Old - Advances in cancer research 2006 cited by 455

  5. Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

    Authors: Paul Sabbatini, Takemasa Tsuji, Luis Ferran, Erika Ritter, Christine Sedrak, Kevin Tuballes, Achim A. Jungbluth, Gerd Ritter, Carol Aghajanian, Katherine M. Bell‐McGuinn, Martee L. Hensley, Jason Konner, William P. Tew, David R. Spriggs, Eric W. Hoffman, Ralph Venhaus, Linda Pan, Andres Μ. Salazar, Catherine Diefenbach, Lloyd J. Old, Sacha Gnjatic - Clinical Cancer Research 2012 cited by 273

  6. Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer

    Authors: Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech‐Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic, Adam R. Karpf - Cancer Immunology Research 2014 cited by 193

  7. RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

    Authors: Michael Schmitt, Anita Schmitt, Markus Rojewski, Jinfei Chen, Krzysztof Giannopoulos, Fei Fei, Yingzhe Yu, Marlies Götz, Marta Heyduk, Gerd Ritter, Daniel E. Speiser, Sacha Gnjatic, Philippe Guillaume, Mark Ringhoffer, Richard F. Schlenk, Peter Liebisch, Donald Bunjes, Hiroshi Shiku, Hartmut Döhner, Jochen Greiner - Blood 2007 cited by 212

  8. Integrated NY-ESO-1 antibody and CD8 + T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

    Authors: Jianda Yuan, Matthew Adamow, Brian Ginsberg, Teresa Rasalan, Erika Ritter, Humilidad F. Gallardo, Yinyan Xu, Evelina Pogoriler, Stephanie Terzulli, Deborah Kuk, Katherine S. Panageas, Gerd Ritter, Mario Sznol, Ruth Halaban, Achim A. Jungbluth, James P. Allison, Lloyd J. Old, Jedd D. Wolchok, Sacha Gnjatic - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 329

  9. Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

    Authors: Kunle Odunsi, Feng Qian, Junko Matsuzaki, Paulette Mhawech‐Fauceglia, Chris Andrews, Eric W. Hoffman, Linda Pan, Gerd Ritter, Jeannine Villella, Bridget V. Thomas, Kerry J. Rodabaugh, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Sacha Gnjatic - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 267

  10. A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor

    Authors: Achim A. Jungbluth, Elisabeth Stockert, Hongyi Huang, V. Peter Collins, Keren Coplan, Kristin Iversen, Denise Kolb, Terrance G. Johns, Andrew M. Scott, William J. Gullick, Gerd Ritter, Leonard Cohen, Matthew J. Scanlan, Webster Cavanee, Lloyd J. Old - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 174

  11. Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

    Authors: Ali O. Güre, Ramon Chua, Barbara Williamson, Mithat Gönen, Cathy A. Ferrera, Sacha Gnjatic, Gerd Ritter, Andrew J.G. Simpson, Yao-T. Chen, Lloyd J. Old, Nasser K. Altorki - Clinical Cancer Research 2005 cited by 364

  12. PEGylated Gold Nanoparticles Conjugated to Monoclonal F19 Antibodies as Targeted Labeling Agents for Human Pancreatic Carcinoma Tissue

    Authors: Wolfgang Eck, Gary A. Craig, Aruna Sigdel, Gerd Ritter, Lloyd J. Old, Laura H. Tang, Murray F. Brennan, Peter J. Allen, Michael D. Mason - ACS Nano 2008 cited by 277

  13. A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma

    Authors: Robert G. Maki, Achim A. Jungbluth, Sacha Gnjatic, Gary K. Schwartz, David R. D’Adamo, Mary Louise Keohan, Michael J. Wagner, Kelly Scheu, Rita Chiu, Erika Ritter, Jennifer Kachel, Israel Lowy, Lloyd J. Old, Gerd Ritter - Sarcoma 2013 cited by 180

  14. Identification of the Epitope for the Epidermal Growth Factor Receptor-specific Monoclonal Antibody 806 Reveals That It Preferentially Recognizes an Untethered Form of the Receptor

    Authors: Terrance G. Johns, Timothy E. Adams, Jennifer R. Cochran, Nathan E. Hall, Peter A. Hoyne, Mark Olsen, Yong‐Sung Kim, Julie Rothacker, Edouard C. Nice, Francesca Walker, Gerd Ritter, Achim A. Jungbluth, Lloyd J. Old, Colin W. Ward, Antony W. Burgess, K. Dane Wittrup, Andrew M. Scott - Journal of Biological Chemistry 2004 cited by 146

  15. CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

    Authors: Jianda Yuan, Sacha Gnjatic, Hao Li, Sarah Powel, Humilidad F. Gallardo, Erika Ritter, Geoffrey Y. Ku, Achim A. Jungbluth, Neil H. Segal, Teresa Rasalan, Gregor Manukian, Yinyan Xu, Ruth-Ann Roman, Stephanie Terzulli, Melanie Heywood, Evelina Pogoriler, Gerd Ritter, Lloyd J. Old, James P. Allison, Jedd D. Wolchok - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 342

  16. Frequent and specific immunity to the embryonal stem cell–associated antigen SOX2 in patients with monoclonal gammopathy

    Authors: Radek Špíšek, Anjli Kukreja, Lin-Chi Chen, Phillip Matthews, Amitabha Mazumder, David H. Vesole, Sundar Jagannath, Henry Zebroski, Andrew J.G. Simpson, Gerd Ritter, Brian G.M. Durie, John Crowley, John D. Shaughnessy, Matthew J. Scanlan, Ali O. Güre, Bart Barlogie, Madhav V. Dhodapkar - The Journal of Experimental Medicine 2007 cited by 199

  17. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

    Authors: Kunle Odunsi, Junko Matsuzaki, Julia Karbach, Antje Neumann, Paulette Mhawech‐Fauceglia, Austin Miller, Amy Beck, Carl D. Morrison, Gerd Ritter, Heidi Godoy, Shashikant Lele, Nefertiti C. duPont, Robert P. Edwards, Protul Shrikant, Lloyd J. Old, Sacha Gnjatic, Elke Jäger - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 198

  18. High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

    Authors: Jochen Greiner, Anita Schmitt, Krzysztof Giannopoulos, Markus Rojewski, Mario E. Götz, I. Funk, Mark Ringhoffer, Donald Bunjes, Susanne Hofmann, Gerd Ritter, Hartmut Döhner, Michael Schmitt - Haematologica 2010 cited by 139

  19. Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

    Authors: Marcus P. Kelly, Achim A. Jungbluth, B-W Wu, John S. Bomalaski, Lloyd J. Old, Gerd Ritter - British Journal of Cancer 2011 cited by 123

  20. The crystal structure of human CD1d with and without α-galactosylceramide

    Authors: Michael Koch, Victoria S. Stronge, Dawn Shepherd, Stephan D. Gadola, Bini Mathew, Gerd Ritter, Alan R. Fersht, Gurdyal S. Besra, Richard R. Schmidt, E. Yvonne Jones, Vincenzo Cerundolo - Nature Immunology 2005 cited by 389

  21. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

    Authors: Danila Valmori, Naira E. Souleimanian, Valeria Tosello, Nina Bhardwaj, Sylvia Adams, David O’Neill, Anna C. Pavlick, Juliet Escalon, Crystal Cruz, Angelica Angiulli, Francesca Angiulli, Gregory Mears, Susan Vogel, Linda Pan, Achim A. Jungbluth, Eric W. Hoffmann, Ralph Venhaus, Gerd Ritter, Lloyd J. Old, Maha Ayyoub - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 295

  22. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

    Authors: Kunle Odunsi, Achim A. Jungbluth, Elisabeth Stockert, Feng Qian, Sacha Gnjatic, Jonathan Tammela, Marilyn Intengan, Amy Beck, Bernadette Keitz, Darren Santiago, Barbara Williamson, Matthew J. Scanlan, Gerd Ritter, Yao‐Tseng Chen, Deborah Driscoll, Ashwani Sood, Shashikant Lele, Lloyd J. Old - 2003 cited by 252

  23. A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

    Authors: Andrew M. Scott, Fook-Thean Lee, Niall C. Tebbutt, Rebecca Herbertson, Sanjeev Gill, Zhanqi Liu, Effie Skrinos, Carmel Murone, Timothy Saunder, Bridget Chappell, Anthony T. Papenfuss, Aurora Poon, Wendie Hopkins, Fiona E. Smyth, Duncan MacGregor, Lawrence Cher, Achim A. Jungbluth, Gerd Ritter, Martin W. Brechbiel, Roger Murphy, Antony W. Burgess, Eric W. Hoffman, Terrance G. Johns, Lloyd J. Old - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 217

  24. Survey of naturally occurring CD4 + T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

    Authors: Sacha Gnjatic, Djordje Atanackovic, Elke Jäger, Mitsutoshi Matsuo, Annamalai Selvakumar, Nasser K. Altorki, Robert G. Maki, Bo Dupont, Gerd Ritter, Yao‐Tseng Chen, Alexander Knuth, Lloyd J. Old - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 201